Skip to content

Entelexo Biotherapeutics

YC W21 · Active · Creating a New Class of Drugs to Address Incurable Autoimmune Diseases

Competitors

Adjacent

Also from W21

All of W21

About Entelexo Biotherapeutics

Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.

YC batch
W21 · Winter 2021
Status, per YC
Active
Category
Other
Team size
3
Location
Irvine, CA, USA
Checked
1h ago

YC tags: Biotech

Entelexo Biotherapeutics in W21: 336 companies, 30% AI

Entelexo Biotherapeutics: questions

Which YC batch was Entelexo Biotherapeutics in?

Entelexo Biotherapeutics was in Y Combinator's Winter 2021 batch (W21).

Is Entelexo Biotherapeutics still active?

Y Combinator lists Entelexo Biotherapeutics as active.

Where is Entelexo Biotherapeutics based?

Entelexo Biotherapeutics lists Irvine, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.